Work

Diagnostisches und therapeutisches Regime implantatassoziierter Infektionen in der Endoprothetik des Hüft- und Kniegelenks unter besonderer Berücksichtigung des Biofilms

Year: 2013
Type: dissertation
Abstract: Implantations of prosthetic joints of hip and knee are already today the most common orthopaedic procedures. Regarding the demographic change in Germany the number of patients will even increase in future. Infections associated with prosthetic joints are rare but represent the most devastating complication with high morbidity and substantial cost. Implant-associated infections are typically caused by microorganisms growing in structures known as biofilms. This fact has to be considered concerning diagnosis, therapy and prophylaxis of prosthetic joint-associated infections. There is a lack of well-designed prospective, randomised and controlled studies with a sufficient follow-up period. Therefore diagnosis, treatment and prophylaxis of prosthetic joint infections are mainly based on tradition and personal experience. The paper is based on publications of international journals which were determined by a Medline research. Publications from the year 1975 until now were considered. The following results were determined. 1. Silver-coated nanoparticles with a great bactericidal potential are used to prevent periprosthetic infections. Silver-coated nanoparticles in bactericidal concentrations show no significant cyto- or genotoxicity. 2. Infections associated with prosthetic joints are classified as early, delayed or late by TRAMPUZ und ZIMMERLI (2008). MCPHERSON et al. (2002) distinguish between acute and chronic infection depending on the respective duration of infection. 3. Infection that is associated with prosthetic joints is typically caused by microorganisms growing in biofilms. The presence of a subcutaneous foreign body reduces the minimal inoculum of bacteria that is required to cause infection at least partially due to a locally acquired granulocyte defect. Regarding persistence there is the accumulative phase during which bacterial cells adhere to each other and create a biofilm. The release of cell-to-cell signalling molecules (’quorum-sensing’), the slow- or non-growing state in the biofilm or the formation of ’small colony variants’ are responsible for causing persistent infections and high resistance against antibiotics. Fungi, especially Candida albicans, can also form biofilms. There are even polymicrobial biofilms with bacteria and fungi similar to symbiosis. 4. The most commonly identified microorganisms causing prosthetic joint infections of hip and knee are gram-positive cocci, especially Staphylococcus aureus and coagulase-negative staphylococci. Early infections are typically caused by virulent microorgansims. 5. A superficial surgical site infection, a surgical patient index score of 1 or 2, the presence of a malignancy and a history of prior joint arthoplasty were identified as independent risk factors concerning hip and knee prosthetic joint infection.Wounds have to be checked regularly postoperative to prevent superficial surgical site infection. Bacteraemia is a risk factor in particular for haematogenous prosthetic joint infection. 6. There are direct (specific) and indirect (non-specific) diagnostic possibilities concerning prosthetic joint infections of hip and knee. Only the direct one’s (puncture and biopsy with following incubation, limited PCR without resistance testing) allow a detection of pathogens and a antimicrobial susceptibility testing for the right therapy. At least five intraoperative periprosthetic tissue specimens should be sampled for culture with a incubation time of at least 14 days. This approach is considered as the most reliable detection method. 7. If the implanted material is removed it can be cultured in enrichment broth media. The use of sonication to dislodge microorganisms from the surface of explanted devices may increase the sensitivity of the culture. 8. Antimicrobial therapy must always be combined with the correct surgical treatment for the optimal therapy of prosthetic joint infections of hip and knee. 9. The most common surgical procedure is a two-stage exchange with the highest success rate usually exceeding 90 %. 10. In staphylococcal implant-associated infections a rifampicin combination should be used with a success rate usually exceeding nearly 100 %. 11. Antibiotic-impregnated bone cement should be used in case of septic prosthetic revisions with significant higher cure rates. 12. An additive therapy in conjunction with the surgical débridement is the use of the antiseptic-acting and well tolerated polyhexanide. In combination with surfactants (e.g. Prontosan®), polyhexanide products are able to break biofilms and support at least partially the removing of biofilms. This doesn’t replace the necessary exchange of implants in case of a manifest infect. 13. A first-generation or second-generation cephalosporin are preferred for perioperative antimicrobial prophylaxis of prosthetic joint infections of hip and knee. If there are contraindications for the use of cephalosporins such as resistance, glycopepides are alternative options. A short period of prophylactic efficacy of three hours has been observed. So if the orthopaedic procedure lasts more than three hours a second dose of antibiotic prophylaxis will be indicated intraoperativly. 14. There is no evidence for the routine use of antibiotic prophylaxis concerning late haematogenous infections during procedures with potential bacteraemia, for example dental treatment. It should be considered in patients with increased risk of haematogenous prosthetic joint infections by using a singledose prophylaxis with oral amoxicillin or clindamycin one hour prior to the dental procedure. Infections are the most devastating complications after implantation of prosthetic joints. Implant-associated infections are typically caused by microorganisms growing in structures known as biofilms. Because of the better understanding concerning the pathogenesis of biofilm forming microorganisms much progress in diagnosis and treatment of prosthetic joint infections of hip and knee has been already achieved during the last decade. There is a great number of new approaches to counteract the biofilm formation. The better understanding of the bacterial cell-cell-communication, especially the complex regulatory process termed ’quorum-sensing’, establish new targets for the antimicrobial therapy. Furanones and the RIP promise success in the future. Farnesol, a quorum-sensing molecule, inhibits the filamentous growing of Candida albicans and prevents in higher concentrations almost completely the formation of biofilms. Rifampicin combinations should be used because this drug has an excellent efficacy on slow-growing and surface-adhering microorganisms. New rifamycin derivates are promising agents for the treatment of staphylococcal implant-associated infections including MRSA since they lack strict cross resistance to rifampicin. In addition to silver-coated nanoparticles also quarternary ammonium compounds seem to be success-promising. Although in vitro and animal studies of novel antimicrobial compunds have shown promise their long-term efficacy and safety in orthopaedic infections have yet to be determined in vivo. Regarding the demographic change prosthetic joint-associated infections will remain present in future. Well-designed studies are needed to have a better validity concerning diagnosis, treatment and prophylaxis of prosthetic joint infections of hip and knee. An evidence-based approach could be sought.
Author: Simone Ruf
Language: German
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W3152893651
Cites: 356
Cited by:
Related to: 10